Anti-hypercholesterolemic drug combination
US6680340B2 · kind B2 · utility
9Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2003 |
| Grant date | Jan 20, 2004 |
| Priority date | — |
| Expiry date | Feb 13, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a drug combination comprised of a thyroid hormone receptor beta agonist with a fibrate in therapeutically effective amounts, which is useful for reducing cholesterol synthesis, lowering plasma cholesterol levels and lowering plasma triglyceride levels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.